BRCA2 and breast cancer: The observed lack of effective treatments for ER-positive BRCA2-associated breast cancer requires attention, and future research needs to be conducted to evaluate the contribution of newer treatments, including platinum-based chemotherapy, oophorectomy and PARP inhibitors.